Amit Batla1, Véronique Phé2,3, Lorenzo De Min2, Jalesh N Panicker2. 1. Department of Motor neuroscience and Movement Disorders UCL Institute of Neurology London United Kingdom. 2. Department of Uro-Neurology The National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology London United Kingdom. 3. Pitié-Salpêtrière Academic Hospital Department of Urology Assistance Publique-Hôpitaux de Paris Pierre and Marie Curie Medical School, Paris 6 University Paris France.
Abstract
BACKGROUND: Nocturia is one of the commonest nonmotor symptoms in Parkinson's disease (PD) and has a significant impact on quality of life both for patients and their carers. There exists a relation between nocturia and poor sleep quality, falls, and institutionalization. Nocturia may manifest as a result of reduced functional bladder capacity or nocturnal polyuria; however, most often the cause is multifactorial. Disorders of circadian rhythm regulation are known to occur with sleep disturbances in PD may also contribute to nocturia. METHODS AND RESULTS: In this review, an overview of the assessment and management of nocturia in patients with PD is presented. History taking, medication review, and a bladder diary form the cornerstone of the evaluation. Urinalysis, ultrasonography, and urodynamic studies help to assess the cause for lower urinary tract symptoms and exclude concomitant pathologies, such as bladder outlet obstruction. Antimuscarinic medications are the first-line treatment for the overactive bladder; however, caution is needed when using these medications in individuals predisposed to cognitive impairment. Desmopressin is effective for managing nocturnal polyuria. CONCLUSIONS: An individualized approach is recommended to optimize the management of nocturia in PD.
BACKGROUND: Nocturia is one of the commonest nonmotor symptoms in Parkinson's disease (PD) and has a significant impact on quality of life both for patients and their carers. There exists a relation between nocturia and poor sleep quality, falls, and institutionalization. Nocturia may manifest as a result of reduced functional bladder capacity or nocturnal polyuria; however, most often the cause is multifactorial. Disorders of circadian rhythm regulation are known to occur with sleep disturbances in PD may also contribute to nocturia. METHODS AND RESULTS: In this review, an overview of the assessment and management of nocturia in patients with PD is presented. History taking, medication review, and a bladder diary form the cornerstone of the evaluation. Urinalysis, ultrasonography, and urodynamic studies help to assess the cause for lower urinary tract symptoms and exclude concomitant pathologies, such as bladder outlet obstruction. Antimuscarinic medications are the first-line treatment for the overactive bladder; however, caution is needed when using these medications in individuals predisposed to cognitive impairment. Desmopressin is effective for managing nocturnal polyuria. CONCLUSIONS: An individualized approach is recommended to optimize the management of nocturia in PD.
Authors: David P Breen; Romina Vuono; Upekshani Nawarathna; Kate Fisher; John M Shneerson; Akhilesh B Reddy; Roger A Barker Journal: JAMA Neurol Date: 2014-05 Impact factor: 18.302
Authors: Ana Gómez-López; Arantxa Sánchez-Sánchez; Elena Natera-Villalba; Victoria Ros-Castelló; Álvaro Beltrán-Corbellini; Samira Fanjul-Arbós; Isabel Pareés Moreno; José Luis López-Sendon Moreno; Juan Carlos Martínez Castrillo; Araceli Alonso-Canovas Journal: Brain Sci Date: 2021-01-06
Authors: Fernando Rodriguez-Sanchez; Carmen Rodriguez-Blazquez; Concha Bielza; Pedro Larrañaga; Daniel Weintraub; Pablo Martinez-Martin; Alexandra Rizos; Anette Schrag; K Ray Chaudhuri Journal: Sci Rep Date: 2021-12-08 Impact factor: 4.379